$83.80
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Country

IE

CEO

Mr. Geoffrey Martha

IPO date

1977

Employees

95,000

ISIN

IE00BTN1Y115

Key stats

Open

$82.90

Volume

7.19M

Market cap

$105.46B

Prev. close

$83.87

Impl / hst vl

-

Open interest

$0.00

$82.50

Day’s Range

$84.19

$73.31

52W Range

$105.50

Valuation

55
Valuation score
Fairly Valued
P/E
21.81
P/S
2.88
P/B
2.12
Current ratio
2.13
Debt / Equity
0.53
ROE
9.85%
Gross margin
65.36%
Income growth
8.84%
FCF growth
-9.22

Jul

17

Dividends

The last payment date was Jul 17, 2026

Div. per Share

$0.72

Div. Yield

0.87%

Payout Ratio

75.78%

Div. Growth YoY

1.41%

Analysts estimates

Consensus rating
Hold

The average rating from top 14 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$99.87
The top 30 analysts forecasts that 12-month price may increase by 19.17%, with a low of $78.78 and a high of $127.05
$78.78
Low
$99.87
Avg
$127.05
High
Current price

Earnings

Q2 ‘26 revenue
$9.81B
Q2 ‘26 net income
$1.24B
Revenue
Net income
Previous EPS
$1.36
Estimate EPS
$1.35
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply